Free Trial
NYSE:PBH

Prestige Consumer Healthcare Q2 2027 Earnings Report

Prestige Consumer Healthcare logo
$47.30 -0.27 (-0.57%)
As of 02:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Prestige Consumer Healthcare EPS Results

Actual EPS
N/A
Consensus EPS
$1.07
Beat/Miss
N/A
One Year Ago EPS
N/A

Prestige Consumer Healthcare Revenue Results

Actual Revenue
N/A
Expected Revenue
$329.15 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Prestige Consumer Healthcare Announcement Details

Quarter
Q2 2027
Time
Before Market Opens
Conference Call Date
Thursday, November 5, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Prestige Consumer Healthcare Earnings Headlines

NNVC Is Heading Into a Big Moment
NanoViricides (NYSE American: NNVC) is moving NV-387 into a Phase II trial for Ebola in the Democratic Republic of Congo, where the Bundibugyo ebolavirus outbreak carries a crude fatality rate above 48 percent. NV-387 is being tested as an oral antiviral, a potential edge over infusion-based treatments. The candidate also holds FDA Orphan Drug and Rare Pediatric Disease designations for measles, giving the platform a second clinical pathway.tc pixel
See More Prestige Consumer Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prestige Consumer Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your email.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare (NYSE:PBH) (NYSE: PBH) is a consumer healthcare company that develops, markets and distributes over-the-counter (OTC) products and household health-care brands. Its portfolio includes products for eye care, oral care, gastrointestinal health, pain relief, respiratory health, women’s health, and other everyday health needs.

The company’s brands include Dramamine, Bonine, BC, Goody’s, Clear Eyes, TheraTears, Monistat, Summer’s Eve, Vagisil, Luden’s, Chloraseptic, Compound W, Fleet and Debrox. Prestige generally focuses on established, recognizable brands that are sold through drugstores, mass merchants, grocery stores, e-commerce channels and other retail outlets.

Prestige Consumer Healthcare traces its origins to the acquisition and development of consumer health brands and has expanded primarily through brand acquisitions. The company serves consumers principally in the United States and Canada, with select products distributed in international markets. It is headquartered in Tarrytown, New York.

View Prestige Consumer Healthcare Profile